CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Epigenomics AG Company Snapshot
Epigenomics AG operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Epigenomics AG with three other pharmaceutical manufacturers in Europe: Bone Therapeutics SA of BELGIUM (2020 sales of 1.00 million Euros [US$1.16 million] ), Oncimmune Holdings PLC of UNITED KINGDOM (£509,000.00 [US$695,355.08 ] of which 100% was Distribution of testing products), and Genincode PLC which is also based in UNITED KINGDOM (£960,801.00 [US$1.31 million] of which 100% was Medical Equipment).

Sales Analysis. During the second quarter of 2021, sales at Epigenomics AG totalled 117,000.00 Euro. This is an increase of 41.0% from the 83,000.00 Euro in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled 223,000.00 Euro, which is 30.7% lower than through the first two quarters of 2020. Epigenomics AG reported sales of 842,000.00 Euro (US$975.67 thousand) for the year ending December of 2020. This represents a sharp decrease of 25.2% versus 2019, when the company's sales were 1.13 million Euro. Contributing to the drop in overall sales was the 75.9% decline in Licenses, from 137,000.00 Euro to 33,000.00 Euro. There were also decreases in sales in Products Sales (Own and Third Party) (down 40.9% to 584,000.00 Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Epigenomics AG
  Stock Performance Chart for Epigenomics AG
 
  Stock Data: Recent Stock Performance:
  Current Price (10/8/2021): 1.02
(Figures in Euros )
1 Week -14.7%   13 Weeks -13.8%  
4 Weeks -18.9%   52 Weeks -94.8%  
 
Epigenomics AG Key Data:
  Ticker: ECX Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2020 Sales 842,000
(Year Ending Jan 2021).
Employees: 37
  Currency: Euros Market Cap: 12,106,984
  Fiscal Yr Ends: December Shares Outstanding: 11,823,227
  Share Type: STAMMAKTIE Closely Held Shares: 3,681,480
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.